Monthly Archives: July 2025

Abivax: Ahead of a bright future?

        Btobioinnovation.com  Author: Jean-Claude Muller, Executive Editor at BtoBioInnovation  jcm9144@gmail.com     SPECIAL REPORT 25.07   Abivax: Ahead of a bright future?   On Tuesday, July 22, just after the closure of Wall Street, Abivax announced positive phase 3 results for the treatment of ulcerative colitis (UC). The Paris and Boston-based biotechnology company […]

read more

Last News

Events

News archives

About this site

BtoBioInnovation proposes outsourced marketing & business development services to Biotech, BioPharma, Life sciences, In vitro Diagnostics, Medtech, Neutraceutic, Cosmetic companies.

BtoBio Innovation

Our services

Future trends, advising for deal making, negociation, due diligence, in and out licensing opportunities, Chinese partnering , operational marketing, representation on business conventions, lead customers, distributors & partners identification.

News & Events

 
Copyright 2018 © BtoBioInnovation
based on a design by inkthemes.com